Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Gain Therapeutics (NASDAQ:GANX) Q3 Loss of USD 0.07 Per Share Beats Estimate; Filing Cites Going Concern Doubt

Research and development expenses for the nine months decreased USD 1.5 million to USD 6.3 million, while general and administrative expenses rose USD 0.5 million to USD 6.9 million. The accumulatedDeficitstood at USD 114.8 million, compared with USD 101.4 million at the end of …

Nitish Kishor | 12 November 2026

GEN Restaurant Group (NASDAQ:GENK) Q3 Revenue Misses Estimate as Binding Letter of Intent Targets Restaurant Sale

Restaurant revenue was USD 44.0 million, down 12.7%, reflecting a 9.2% decline in comparable restaurant sales and fewer restaurants. The company generated USD 4.7 million of consumer packaged goods revenue against none a year earlier, and retail distribution expanded to more than 2,000 doors.

Nitish Kishor | 12 November 2026

Gevo (NASDAQ:GEVO) Q3 Revenue Reaches USD 83 Million With Carbon Credit Recognition

Management citedGross Profitof USD 48 million, adjusted EBITDA of USD 44 million and cash flow from operations of USD 41 million, and said the company ended the quarter with USD 68 million of cash. The call described the results as significant beyond a single …

Nitish Kishor | 12 November 2026

Gogoro (NASDAQ:GGR) Reports Record Q3 Gross Margin of 24.4% as Revenue Falls 9.1% to USD 70.6 Million

Management said the decline reflects continued pressure on its hardware businesses amid challenging market conditions. Net loss narrowed by USD 11.5 million to USD 3.4 million, against USD 14.9 million a year earlier. Non-IFRS net loss improved to USD 3.9 million from USD 6.7 …

Nitish Kishor | 12 November 2026

Gilat Satellite Networks (NASDAQ:GILT) Q3: Non-GAAP EPS Beats at USD 0.18, but Revenue Trails Estimate

Non-GAAP net income was USD 14.3 million, compared with USD 11.8 million a year earlier. Adjusted EBITDA reached USD 17.6 million, up from USD 15.6 million. For the first nine months, revenue was USD 349.4 million and adjusted EBITDA was USD 48.1 million.

Nitish Kishor | 12 November 2026

Grocery Outlet (NASDAQ:GO) Q3 Adjusted EPS of USD 0.16 Matches Estimate as Comparable Sales Rise 0.5%

Management said comparable sales reflected a 2.4% increase in traffic, partly offset by a 1.9% decrease in basket, and that traffic growth was driven by new customers.GAAPNet Incomewas USD 13.3 million, or USD 0.13 per diluted share, against USD 11.6 million, or USD 0.12.

Nitish Kishor | 12 November 2026

Gossamer Bio (NASDAQ:GOSS) Q3 Revenue Beats Estimate as Loss Per Share Runs Wider Than Forecast

Net loss was USD 48.1 million against USD 48.2 million a year earlier, and USD 77.8 million for the nine months against USD 123.1 million.Research and Developmentexpense was USD 18.8 million against USD 45.5 million, a decrease of USD 26.7 million that the filing …

Nitish Kishor | 12 November 2026

Grove Collaborative Holdings (NYSE:GROV) Q3 Net Revenue Falls 15.8% to USD 36.8 Million but Adjusted EBITDA Turns Positive

The filing reportsNet Incomeof USD 0.1 million for the quarter and a net loss of USD 1.8 million for the nine months, which compares with a nine-month net loss of USD 10.1 million a year earlier and operating cash use of USD 6.9 million …

Nitish Kishor | 12 November 2026

GrowGeneration (NASDAQ:GRWG) Q3 Revenue Is USD 44.8 Million With Gross Margin at 32.4%

Management said revenue was in line with its guidance range and slightly lower than a year earlier because of a few large one-time transactions in the prior year period.

Nitish Kishor | 12 November 2026

Harvard Bioscience (NASDAQ:HBIO) Q3 Loss of USD 0.06 Beats Estimate as Revenue Grows 8%

Management cited strength across key preclinical platforms, with double-digit momentum in products for organoids and fluidics and in newly introduced products. Revenue from its Chinese distribution partners grew 31%.

Nitish Kishor | 12 November 2026
Support

Hi! How can we help you today?

Loading…